A patient with type 2 diabetes has an A1C of 9.2% despite metformin monotherapy. Which medication class is MOST appropriate to add given the patient also has established cardiovascular disease?
-
A
Sulfonylurea
-
B
GLP-1 receptor agonist
-
C
DPP-4 inhibitor
-
D
Alpha-glucosidase inhibitor